LOS ANGELES (KABC) -- The newly FDA-approved bionic pancreas uses artificial intelligence to make life with type 1 diabetes much more manageable. Mia Campos, 15, is a skilled gymnast. She's also been ...

Beta Bionics Inc., which makes ­a “bionic pancreas,” has secured $60 million in a Series E funding round led by new investor Wellington Management. The funding fuels Beta Bionics’ continued ...

Please provide your email address to receive an email when new articles are posted on . The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with type 1 ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship G7 sensor. The new system, which boosts wear time up from the previous ...

Several companies showed promising results for automated insulin delivery (AID) systems at the American Diabetes Association (ADA) annual meeting in New Orleans. Studies of the systems, also known as ...

Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...

Beta Bionics plans to integrate its iLet Bionic Pancreas with Abbott's upcoming dual glucose-ketone sensor for enhanced diabetes management. Beta Bionics, Inc. has announced plans to integrate its ...